Higher vitamin B12 levels in neurodevelopmental disorders than in healthy controls and schizophrenia: A comparison among participants between 2 and 53 years. Issue 6 (22nd April 2020)
- Record Type:
- Journal Article
- Title:
- Higher vitamin B12 levels in neurodevelopmental disorders than in healthy controls and schizophrenia: A comparison among participants between 2 and 53 years. Issue 6 (22nd April 2020)
- Main Title:
- Higher vitamin B12 levels in neurodevelopmental disorders than in healthy controls and schizophrenia
- Authors:
- Hope, Sigrun
Nærland, Terje
Høiland, Anne Lise
Torske, Tonje
Malt, Eva
Abrahamsen, Tore
Nerhus, Mari
Wedervang–Resell, Kirsten
Lonning, Vera
Johannessen, Jarle
Steen, Nils Eiel
Agartz, Ingrid
Stenberg, Nina
Hundhausen, Thomas
Mørkrid, Lars
Andreassen, Ole A. - Abstract:
- Abstract: Recent studies suggest that both high and low levels of vitamin B12 (vitB12) may have negative health impacts. We measured VitB12 in patients with the Neurodevelopmental disorders (ND) (n = 222), comprised of Autism Spectrum Disorders, specific Developmental disorders, and Intellectual Disability (aged 2‐53 years), schizophrenia (n = 401), and healthy controls (HC) (n = 483). Age‐and gender‐adjusted vitB12 z‐scores were calculated by comparisons with a reference population (n = 76 148). We found higher vitB12 in ND (median 420 pmol/L, mean z‐score: 0.30) than in HC (316 pmol/L, z‐score: 0.06, P < .01) and schizophrenia (306 pmol/L, z‐score: −0.02, P < .001), which was significant after adjusting for age, gender, vitB12 supplement, folate, hemoglobin, leukocytes, liver, and kidney function ( P < .02). In ND, 20% (n = 44) had vitB12 above 650 pmol/L, and 1% (n = 3) had below 150 pmol/L (common reference limits). In 6.3% (n = 14) of ND, vitB12 was above 2SD of mean in the age‐and gender‐adjusted reference population, which was more frequent than in HC (n = 8, 1.6%), OR: 4.0, P = .001. Low vitB12 was equally frequent as in HC, and vitB12 z‐scores were equal across the age groups. To conclude, vitB12 was higher in ND than in HC and schizophrenia, suggesting a specific feature of ND, which warrants further studies to investigate the underlying mechanisms.
- Is Part Of:
- FASEB journal. Volume 34:Issue 6(2020)
- Journal:
- FASEB journal
- Issue:
- Volume 34:Issue 6(2020)
- Issue Display:
- Volume 34, Issue 6 (2020)
- Year:
- 2020
- Volume:
- 34
- Issue:
- 6
- Issue Sort Value:
- 2020-0034-0006-0000
- Page Start:
- 8114
- Page End:
- 8124
- Publication Date:
- 2020-04-22
- Subjects:
- autism -- cobalamin -- hypercobalaminemia -- intellectual disability -- TCN1
Biology -- Periodicals
Biology, Experimental -- Periodicals
570 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1096/fj.201900855RRR ↗
- Languages:
- English
- ISSNs:
- 0892-6638
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18712.xml